» Articles » PMID: 19875378

Recurrence of Focal Segmental Glomerular Sclerosis (FSGS) After Renal Transplantation

Overview
Date 2009 Oct 31
PMID 19875378
Citations 53
Authors
Affiliations
Soon will be listed here.
Citing Articles

A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING).

C Willcocks L, Qian W, Cader R, Gatley K, Siddiqui H, Tabebisong E BMC Nephrol. 2024; 25(1):253.

PMID: 39112932 PMC: 11308314. DOI: 10.1186/s12882-024-03576-0.


Five-Year study on renal outcomes in biopsy-proven focal segmental glomerulosclerosis patients in Shiraz, Iran.

Pakfetrat M, Malekmakan L, Rezazadeh M, Tadayon T, Bahmani M, Nikoo A Caspian J Intern Med. 2024; 15(3):519-526.

PMID: 39011448 PMC: 11246676. DOI: 10.22088/cjim.15.3.519.


Plasma exchange or immunoadsorption for recurrent focal segmental glomerulosclerosis: clear differences in vitro.

Veissi S, Smeets B, van Wijk J, van der Velden T, van den Heuvel L, Schreuder M Nephrol Dial Transplant. 2022; 37(11):2293-2294.

PMID: 36083975 PMC: 9585456. DOI: 10.1093/ndt/gfac255.


Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.

Uffing A, Hullekes F, Hesselink D, Mansur J, Malvezzi P, de Vries A Kidney Int Rep. 2022; 7(6):1424-1427.

PMID: 35685308 PMC: 9171618. DOI: 10.1016/j.ekir.2022.03.002.


A Single-center, Retrospective Study of Focal Segmental Glomerulosclerosis after Kidney Transplantation: Evolutive Analysis.

Ferreira da Mata G, Mansur J, Riguetti M, Rezende G, Osmar de Medina Pestana J, Mastroianni Kirsztajn G Int J Organ Transplant Med. 2022; 12(3):1-10.

PMID: 35509723 PMC: 9013500.